AUTL

Latest SEC Filings & News for AUTL

2 most recent filings and news items mentioning AUTL. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/AUTL/news?limit=20"

Pull AUTL filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Offering|GuidanceAug 3, 2026Positive

Autolus Preliminary Q2 2026 Net Product Revenue $45M

Autolus reports preliminary Q2 2026 net product revenue of approximately $45 million and increased FY 2026 sales guidance to $140–$150 million. The company also announced a strategic financing agreement with Perceptive Advisors for up to a $250 million credit facility.

View filing at SEC.gov →

OtherJun 9, 2026Neutral

Autolus Therapeutics releases 2025 annual report and financial statements

Autolus Therapeutics plc, a Nasdaq-listed biopharmaceutical company, published its annual report and consolidated financial statements for the year ended December 31, 2025. The filing provides comprehensive financial performance data and corporate governance information for the c

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.